We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biomaterial Scaffolds Boost Interleukin Production to Promote Wound Healing

By LabMedica International staff writers
Posted on 29 Apr 2016
The improved wound healing promoted by use of "biomaterial" scaffolds was shown to be due to activation of the immune system's T helper II pathway with a subsequent increase in production of interleukins.

Biomaterial scaffolds derived from cardiac muscle and bone extracellular matrix components help to guide regenerating tissue. More...
Investigators at Johns Hopkins University (Baltimore, MD, USA) tested how such biomaterial scaffolds interact with the immune system in damaged tissue to promote repair.

They reported in the April 15, 2016, issue of the journal Science that scaffolds induced a pro-regenerative response, characterized by an mTOR/Rictor-dependent T helper II pathway that guided interleukin-4 (IL4) – dependent macrophage polarization, which was critical for functional muscle recovery. Mice that had been genetically engineered to lack T-cells did not activate interleukin production or heal as well as normal mice.

"In previous research, we have seen different immune system responses to the same biomaterial implanted in different tissues or environments, and that got us interested in how biomaterials might stimulate the immune system to promote regeneration," said senior author Dr. Jennifer Elisseeff, professor of ophthalmology and biomedical engineering at Johns Hopkins University. "We still have a lot to learn, but this study is a step toward designing materials to elicit a beneficial immune response."

Related Links:
Johns Hopkins University


New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Pipette Calibration System
Artel PCS®
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.